A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma
Clinical trial NCT01170663 · COMPLETED
Trial details
- NCT number
- NCT01170663
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-07-01
- Enrollment
- 665
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.